BET proteins bolster the functions of key oncogenes by increasing the expression of these drivers, such as c-MYC in leukemia [124,125], or by enhancing the transcriptional activities of oncogenic factors, such as Androgen receptor (AR) and Transcription regulator ERG in prostate cancer [126]. The gene discussed is AR; the disease is leukemia.